IntegraMed America Inc. Reports Operating Results (10-Q)

Author's Avatar
May 08, 2009
IntegraMed America Inc. (INMD, Financial) filed Quarterly Report for the period ended 2009-03-31.

IntegraMed America Inc. is a physician practice management company which provides comprehensive management support services to a network of medical providers of women's health care services. The Company's objective is to create and manage a nationwide Network of medical providers of specialty women's health care services that achieves high quality clinical outcomes with maximum cost effectiveness. IntegraMed America Inc. has a market cap of $62.6 million; its shares were traded at around $7.2499 with a P/E ratio of 15.4 and P/S ratio of 0.3. IntegraMed America Inc. had an annual average earning growth of 23.5% over the past 5 years.

Highlight of Business Operations:

Fertility Centers .............. 69.3% 71.8%

Consumer Services .............. 10.0% 8.8%

Vein Clinics ................... 20.7% 19.4%

- -



Fertility Centers .............. 64.3% 66.7%

Consumer Services .............. 7.1% 6.5%

Vein Clinics ................... 19.3% 18.7%

- -

Total cost of services and sales 90.7% 91.9%

- -



Fertility Centers .............. 5.0% 5.1%

Consumer Services .............. 2.9% 2.3%

Vein Clinics ................... 1.4% 0.7%

- -

Total contribution ........ 9.3% 8.1%

- -



General and administrative expenses 6.0% 5.2%

Interest income .................... (0.1)% (0.4)%

Interest expense ................... 0.6% 1.0%

- -

Total other expenses ...... 6.4% 5.8%

- -



Income before income taxes ......... 3.0% 2.3%

Income tax provision ............... 1.2% 0.9%

- -

Net income ......................... 1.8% 1.4%

= =



Each component of our amended credit facility bears interest by reference to

Bank of America's prime rate or LIBOR, at our option, plus a margin, which is

dependent upon a leverage test, ranging from 2.00% to 2.75% in the case of

LIBOR-based loans. Prime-based loans are made at Bank of America's prime rate

and do not contain an additional margin. Interest on the prime-based loans

became payable quarterly beginning November 8, 2007 and interest on LIBOR-based

loans is payable on the last day of each applicable interest period. As of March

31, 2009, interest on the term loan was payable at a rate of 2.75%. Unused

amounts under the working capital revolver bear a commitment fee of 0.25% and

are payable quarterly.



Read the The complete Report